While some clinical observations show that PPARγ expression levels are high in advanced prostate cancer (APC) tissues, ovarian, prostate and testicular carcinoma tissues [52–55], it is unclear whether the high levels of PPARγ correlate with favorite outcome in cancer patients. The gene discussed is PPARG; the disease is cancer.